Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Change in Acquisitions & Divestments (2023 - 2024)

Sagimet Biosciences (SGMT) has 2 years of Change in Acquisitions & Divestments data on record, last reported at $23.6 million in Q4 2024.

  • For Q4 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $23.6 million; the TTM value through Dec 2024 reached $46.4 million, up 44.11%, while the annual FY2025 figure was $111.4 million, 140.11% up from the prior year.
  • Change in Acquisitions & Divestments reached $23.6 million in Q4 2024 per SGMT's latest filing, up from $12.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $23.6 million in Q4 2024 and bottomed at $3.0 million in Q1 2024.